These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4418089)

  • 1. Intrauterine administration of prostaglandin 15 (S) 15 methyl E2 methyl ester in the management of patients with a hydatidiform mole.
    Karim SM; Ratnam SS; Choo HT
    J Obstet Gynaecol Br Commonw; 1974 Aug; 81(8):650-1. PubMed ID: 4418089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular administration of 15(S)-15-methylprostaglandin E2-methyl ester for induction of abortion.
    Brenner WE; Dingfelder JR; Staurovsky LG; Kumarasamy T; Grimes DA
    Am J Obstet Gynecol; 1974 Nov; 120(6):833-6. PubMed ID: 4429093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous intravenous infusion of prostaglandin E2 (PGE2) and oxytocin in the management of intrauterine death of the fetus, missed abortion and hydatidiform mole.
    Naismith WC; Barr W
    J Obstet Gynaecol Br Commonw; 1974 Feb; 81(2):146-9. PubMed ID: 4816026
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose intravenous administration of prostaglandin E 2 and F 2 for the termination of midtrimester pregnancies.
    Hillier K; Embrey MP
    J Obstet Gynaecol Br Commonw; 1972 Jan; 79(1):14-22. PubMed ID: 5021725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
    Karim SM; Choo HT; Cheng P
    Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra amniotic prostaglandins in the management of intrauterine fetal death, anencephaly and hydatidiform mole.
    Embrey MP; Calder AA; Hillier K
    J Obstet Gynaecol Br Commonw; 1974 Jan; 81(1):47-51. PubMed ID: 4818316
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and acceptability of 15(S)-15-methyl-prostaglandin E2-methyl ester for midtrimester pregnancy termination.
    Bieniarz J; Hunter G; Scommegna A
    Am J Obstet Gynecol; 1974 Nov; 120(6):840-3. PubMed ID: 4429095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of missed abortion, intrauterine death and hydatidiform mole using prostaglandin E2.
    Murray CP; Clinch J
    Ir Med J; 1975 Mar; 68(6):133-5. PubMed ID: 1120656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Termination of molar pregnancy by intramuscular administration of 15(S)-15-methyl-prostaglandin F2 alpha.
    Keirse MJ
    Prostaglandins Med; 1980 May; 4(5):333-9. PubMed ID: 7403332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of pregnancy by extraamniotic prostaglandins and the synergistic action of oxytocin.
    Embrey MP; Hillier K; Mahendran P
    Adv Biosci; 1973; 9():507-13. PubMed ID: 4805861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of prostaglandin E2 in the management of missed abortion, missed labour, and hydatidiform mole.
    Karim SM
    Br Med J; 1970 Jul; 3(5716):196-7. PubMed ID: 5448780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular administration of 15(S) 15 methyl prostaglandin E2 methyl ester for induction of abortion: a comparison of two dose schedules.
    Brenner WE; Dingfelder JR; Staurovsky LG; Kumarasamy T; Grimes DA
    Fertil Steril; 1975 Apr; 26(4):369-79. PubMed ID: 1116632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of intramuscularly administered 15(S) 15 methyl prostaglandin E2 methyl ester for induction of artificial abortion.
    Brenner WE; Dingfelder R; Staurovsky LG
    Am J Obstet Gynecol; 1975 Sep; 123(1):19-29. PubMed ID: 1190275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of intravenous prostaglandin E2 and intravenous oxytocin for the augmentation of labour complicated by delay.
    Clegg DR; Flynn AM; Kelly J
    J Obstet Gynaecol Br Commonw; 1974 Dec; 81(12):995-9. PubMed ID: 4452929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL; Bolognese RJ
    J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of labour and abortion by intravenous prostaglandins in pregnancies complicated by intra-uterine foetal death and hydatidiform mole.
    Roberts G
    Curr Med Res Opin; 1974; 2(6):342-50. PubMed ID: 4448100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-trimester abortion with 15 (S) methyl prostaglandin F 2 alpha.
    Leibman T; Saldana L; Schulman H; Cunningham MA; Randolph G
    Prostaglandins; 1974 Sep; 7(5):443-8. PubMed ID: 4424912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Termination of abnormal intrauterine pregnancies with intramuscular administration of dihomo 15 methyl prostaglandin F 2alpha.
    Karim SM; Ratnam SS
    Br J Obstet Gynaecol; 1976 Nov; 83(11):885-9. PubMed ID: 990229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH; Wilson KH
    Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.